MDT and patient perspectives on the long-term management of patients with severe type 2 asthma episode artwork

EPISODE · Jan 14, 2022 · 16 MIN

MDT and patient perspectives on the long-term management of patients with severe type 2 asthma

from touchPODCAST · host touchpodcast

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma.  The multidisciplinary team  Pulmonologist: Professor Alberto Papi, Italy Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity jointly provided by USF Health and touchIME. For further information visit: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//

Episode metadata supplied by the publisher feed · Published Jan 14, 2022

Embed this episode

Ready to play

MDT and patient perspectives on the long-term management of patients with severe type 2 asthma

0:00 16:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 16 minutes long.

When was this touchPODCAST episode published?

This episode was published on January 14, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!